abstract |
The patent describes substituted xanthines of general formula (I) in which R-R have the meanings indicated in claims 1-16, their tautomers, their stereoisomers, their mixtures, their prodrugs and their salts, which have valuable pharmacological properties, primarily inhibiting action on the activity of dipeptidyl peptidase-IV (DPP-IV). |